Cardiovascular Morbidity and Mortality Is Higher in Patients with Thyroid Hormone Resistance β Syndrome than in the General Population

Clinical thyroidology Pub Date : 2023-10-01 DOI:10.1089/ct.2023;35.398-401

Elias Chuki, Amr Dorgham, Joanna Klubo-Gwiezdzinska

{"title":"Cardiovascular Morbidity and Mortality Is Higher in Patients with Thyroid Hormone Resistance β Syndrome than in the General Population","authors":"Elias Chuki, Amr Dorgham, Joanna Klubo-Gwiezdzinska","doi":"10.1089/ct.2023;35.398-401","DOIUrl":null,"url":null,"abstract":"Clinical Thyroidology®Vol. 35, No. 10 Thyroid Hormone ActionCardiovascular Morbidity and Mortality Is Higher in Patients with Thyroid Hormone Resistance β Syndrome than in the General PopulationElias Chuki, Amr Dorgham, and Joanna Klubo-GwiezdzinskaElias ChukiMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, U.S.A.Search for more papers by this author, Amr DorghamMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, U.S.A.Search for more papers by this author, and Joanna Klubo-GwiezdzinskaMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, U.S.A.Search for more papers by this authorPublished Online:5 Oct 2023https://doi.org/10.1089/ct.2023;35.398-401AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 10Oct 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Elias Chuki, Amr Dorgham, and Joanna Klubo-Gwiezdzinska.Cardiovascular Morbidity and Mortality Is Higher in Patients with Thyroid Hormone Resistance β Syndrome than in the General Population.Clinical Thyroidology®.Oct 2023.398-401.http://doi.org/10.1089/ct.2023;35.398-401Published in Volume: 35 Issue 10: October 5, 2023PDF download","PeriodicalId":72629,"journal":{"name":"Clinical thyroidology","volume":"01 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical thyroidology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ct.2023;35.398-401","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Clinical Thyroidology®Vol. 35, No. 10 Thyroid Hormone ActionCardiovascular Morbidity and Mortality Is Higher in Patients with Thyroid Hormone Resistance β Syndrome than in the General PopulationElias Chuki, Amr Dorgham, and Joanna Klubo-GwiezdzinskaElias ChukiMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, U.S.A.Search for more papers by this author, Amr DorghamMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, U.S.A.Search for more papers by this author, and Joanna Klubo-GwiezdzinskaMetabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, U.S.A.Search for more papers by this authorPublished Online:5 Oct 2023https://doi.org/10.1089/ct.2023;35.398-401AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 10Oct 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Elias Chuki, Amr Dorgham, and Joanna Klubo-Gwiezdzinska.Cardiovascular Morbidity and Mortality Is Higher in Patients with Thyroid Hormone Resistance β Syndrome than in the General Population.Clinical Thyroidology®.Oct 2023.398-401.http://doi.org/10.1089/ct.2023;35.398-401Published in Volume: 35 Issue 10: October 5, 2023PDF download

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

甲状腺激素抵抗β综合征患者的心血管发病率和死亡率高于一般人群

临床Thyroidology®卷。35, No. 10甲状腺激素的作用甲状腺激素抵抗β综合征患者的心血管发病率和死亡率高于一般人群elias Chuki, Amr doghham和Joanna klubog - gwiezdzinsska elias Chuki代谢疾病分支，美国马里兰州Bethesda国家糖尿病、消化和肾脏疾病研究所Amr doghham代谢疾病分支，美国国家糖尿病、消化和肾脏疾病研究所查找本作者和Joanna klubo - gwiezdzinska的更多论文，国立糖尿病、消化和肾脏疾病研究所代谢疾病分部，马里兰州贝塞斯达，美国搜索本文作者的更多论文发表在线:2023年10月5日https://doi.org/10.1089/ct.2023;35.398-401AboutSectionsView文章查看全文pdf /EPUB权限和引文下载CitationsTrack引文添加到收藏回到出版分享分享在facebook上推特链接在redditemail查看文章figuresreferencesrelateddetails卷35期10Oct 2023信息©版权所有2023,Mary Ann Liebert，公司。引用本文:Elias Chuki, Amr dogham，Joanna Klubo-Gwiezdzinska。甲状腺激素抵抗β综合征患者的心血管发病率和死亡率高于一般人群。临床Thyroidology®。Oct 2023.398-401.http://doi.org/10.1089/ct.2023;35.398-401Published in Volume: 35 Issue 10: October 5, 2023PDF下载

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Clinical thyroidology

自引率

0.00%

发文量

期刊最新文献

Greetings From the Editor of Clinical Thyroidology Greetings From the Editor of Clinical Thyroidology Jan Wolff Reflects on His Career as He Approaches His 99th Birthday Is There a Role for Radiofrequency Ablation in the Treatment of Graves' Disease? Postoperative Hypothyroidism Management: Weight-Based Levothyroxine Dosing Is an Oversimplification